AbbVie (ABBV) News Today $185.53 -0.09 (-0.05%) Closing price 03:59 PM EasternExtended Trading$186.09 +0.56 (+0.30%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is AbbVie Down Today?AbbVie Inc. (NYSE: ABBV) shares are trading higher today on the back of encouraging clinical data, new partnerships, and an analyst upgrade, even as the company faces several class‐action lawsuits tied to its Cerevel Therapeutics Holdings unit. Announced a multi‐year “Striking Out Cancer” partnership with the Chicago Cubs to raise awareness and support nonprofit cancer organizations. Teamed with Emerson to deploy wireless steam trap monitoring, enhancing plant efficiency and cost savings. Partnered with an oncology research institute to run more diverse and inclusive cancer trials, bolstering its R&D pipeline. Presented promising Phase 1 antibody‐drug conjugate (ADC) results in advanced cancers, underlining pipeline strength. MarketBeat noted a 1.4% intraday gain and reiterated a “buy” rating on ABBV shares. Zacks highlighted a roughly 13% pullback over three months but sees rising Skyrizi and Rinvoq sales and 2025 growth prospects as a long‐term buy‐the‐dip case. Seeking Alpha views AbbVie as fairly valued with solid dividends but lacking a fresh near‐term catalyst. Broader market commentary points to potential rotation into high‐yield dividend stocks—an environment that could benefit AbbVie’s appeal. Multiple class-action lawsuits filed against Cerevel Therapeutics Holdings (ABBV), with June 3 deadlines to join claims alleging investor losses from alleged securities fraud. Posted 7h agoAI Generated. May Contain Errors. ABBV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period AbbVie’s ADC win shows how pharma can break through in solid tumorsMay 30 at 6:49 PM | finance.yahoo.comHow Is AbbVie's Stock Performance Compared to Other Pharmaceuticals Stocks?May 30 at 6:49 PM | msn.comAbbVie (NYSE:ABBV) Stock Price Up 1.4% - Still a Buy?AbbVie (NYSE:ABBV) Trading 1.4% Higher - What's Next?May 30 at 2:08 PM | marketbeat.comClass Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) - June 3, 2025 Deadline to Join – Contact Levi & KorsinskyMay 30 at 12:38 PM | globenewswire.comAbbVie Partners with Chicago Cubs on "Striking Out Cancer"May 30 at 8:00 AM | prnewswire.comFirst Hawaiian Bank Has $6.79 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)First Hawaiian Bank cut its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 7.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,390 shares of the company's stock afteMay 30 at 7:36 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Position Decreased by Park National Corp OHPark National Corp OH cut its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 7.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 127,173 shares of the company's stock after selling 9,524 shares during theMay 30 at 7:04 AM | marketbeat.comNeville Rodie & Shaw Inc. Sells 5,115 Shares of AbbVie Inc. (NYSE:ABBV)Neville Rodie & Shaw Inc. trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 91,515 shares of the company's stock after selling 5,1May 30 at 6:29 AM | marketbeat.comFulcrum Equity Management Decreases Stock Position in AbbVie Inc. (NYSE:ABBV)Fulcrum Equity Management cut its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 49.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,671 shares of the company's stock after selling 3,534 shareMay 30 at 6:13 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit - ABBVMay 30 at 5:45 AM | prnewswire.comAbbVie (NYSE:ABBV) Showcases Promising Phase 1 ADC Results For Advanced CancersMay 29 at 2:01 PM | uk.finance.yahoo.comContact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Cerevel Therapeutics Holdings, Inc.(ABBV)May 29 at 12:22 PM | globenewswire.comAbbVie: Fairly Valued, But Lacking A SparkMay 29 at 9:14 AM | seekingalpha.comWhen $7 Trillion Wakes Up: Buy These 3 Dividend Stocks Before Everyone Else DoesMay 29 at 8:02 AM | seekingalpha.comDSG Capital Advisors LLC Acquires Shares of 18,081 AbbVie Inc. (NYSE:ABBV)DSG Capital Advisors LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 18,081 shares of the company's stock, valued at approximMay 29 at 7:48 AM | marketbeat.comChancellor Financial Group WB LP Takes $981,000 Position in AbbVie Inc. (NYSE:ABBV)Chancellor Financial Group WB LP bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 5,523 shares of the company's stock, valued at approximately $981,000. AbbVie makesMay 29 at 7:40 AM | marketbeat.comThoma Capital Management LLC Invests $551,000 in AbbVie Inc. (NYSE:ABBV)Thoma Capital Management LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,102 shares of the company's stock, valued at approximMay 29 at 7:25 AM | marketbeat.comLansforsakringar Fondforvaltning AB publ Makes New $104.35 Million Investment in AbbVie Inc. (NYSE:ABBV)Lansforsakringar Fondforvaltning AB publ acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 587,210 shares of the company's stock, valued at aMay 29 at 7:00 AM | marketbeat.comPKO Investment Management Joint Stock Co Makes New $2.40 Million Investment in AbbVie Inc. (NYSE:ABBV)PKO Investment Management Joint Stock Co purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 13,500 shares of the company's stock, valued at approximateMay 29 at 6:52 AM | marketbeat.comNorthstar Financial Companies Inc. Takes Position in AbbVie Inc. (NYSE:ABBV)Northstar Financial Companies Inc. bought a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 6,860 shares of the company's stock, valued at approximately $1,219,000. AbbVie comprises 1.2%May 29 at 6:51 AM | marketbeat.comLighthouse Financial LLC Invests $700,000 in AbbVie Inc. (NYSE:ABBV)Lighthouse Financial LLC purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,940 shares of the company's stock, valued at approximately $700,000. A numbMay 29 at 6:26 AM | marketbeat.comMattson Financial Services LLC Sells 1,695 Shares of AbbVie Inc. (NYSE:ABBV)Mattson Financial Services LLC trimmed its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 25.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,010 shares of the company's stock after selling 1,695 shares during thMay 29 at 6:16 AM | marketbeat.comClass Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors - Contact The Gross Law FirmMay 29 at 5:45 AM | prnewswire.comAbbVie Inc. (ABBV)’s Pipeline Advances with Temab-A and ABBV-706, Shares FlatMay 29 at 12:57 AM | insidermonkey.comElite Financial Inc. Purchases New Position in AbbVie Inc. (NYSE:ABBV)Elite Financial Inc. purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,557 shares of the company's stock, valued at approximately $632,000. Other hedge funds and other instiMay 28 at 7:42 AM | marketbeat.comWood Tarver Financial Group LLC Invests $281,000 in AbbVie Inc. (NYSE:ABBV)Wood Tarver Financial Group LLC acquired a new position in AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,585 shares of the company's stock, valued at approximatMay 28 at 7:34 AM | marketbeat.comTFR Capital LLC. Buys New Stake in AbbVie Inc. (NYSE:ABBV)TFR Capital LLC. purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 13,184 shares of the company's stock, valued at approximately $2,343,000. AbbVie mMay 28 at 7:26 AM | marketbeat.com1,537,993 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Universal Beteiligungs und Servicegesellschaft mbHUniversal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,537,993 shares of the coMay 28 at 7:23 AM | marketbeat.comBrooklyn FI LLC Takes $1.08 Million Position in AbbVie Inc. (NYSE:ABBV)Brooklyn FI LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,888 shares of the company's stock, valued at approximately $1,083,000. Several other hedgeMay 28 at 7:22 AM | marketbeat.comBrucke Financial Inc. Makes New Investment in AbbVie Inc. (NYSE:ABBV)Brucke Financial Inc. purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,527 shares of the company's stock, valued at approximately $465,May 28 at 7:14 AM | marketbeat.comBernard Wealth Management Corp. Invests $614,000 in AbbVie Inc. (NYSE:ABBV)Bernard Wealth Management Corp. purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,456 shares of the company's stock, valued at approMay 28 at 6:44 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stake Boosted by Fluent Financial LLCFluent Financial LLC grew its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,161 shares of the company's stock after purchasing an additional 2,307 sharMay 28 at 6:38 AM | marketbeat.comPinnacle Wealth Planning Services Inc. Cuts Stake in AbbVie Inc. (NYSE:ABBV)Pinnacle Wealth Planning Services Inc. trimmed its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,088 shares of the company's stock after selling 2,985 shares during the quarter. PiMay 28 at 6:35 AM | marketbeat.com14,719 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Total Wealth Planning & Management Inc.Total Wealth Planning & Management Inc. bought a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,719 shares of the company's stock, valued at approximately $2,616,000.May 28 at 6:22 AM | marketbeat.comHeck Capital Advisors LLC Invests $952,000 in AbbVie Inc. (NYSE:ABBV)Heck Capital Advisors LLC acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,358 shares of the company's stock, valued at apprMay 28 at 6:09 AM | marketbeat.comArmis Advisers LLC Takes $436,000 Position in AbbVie Inc. (NYSE:ABBV)Armis Advisers LLC acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 2,452 shares of the company's stock, valued at approximately $436,000. A number of other large investors haveMay 28 at 6:00 AM | marketbeat.comBest Dividend Aristocrats For June 2025May 27 at 10:33 PM | seekingalpha.comAbbVie To Present Cancer Trial Data At Upcoming ASCO EventMay 27 at 12:02 PM | benzinga.comAbbVie Features New Data Across Difficult-to-Treat Solid Tumors and Blood Cancers at ASCO 2025, Highlighting Breadth and Depth of its Oncology PortfolioMay 27 at 9:00 AM | prnewswire.comLeigh Baldwin & CO. LLC Takes Position in AbbVie Inc. (NYSE:ABBV)Leigh Baldwin & CO. LLC bought a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,739 shares of the company's stock, valued at approximately $309,000. Other institutionaMay 27 at 7:25 AM | marketbeat.comB. Riley Wealth Advisors Inc. Sells 2,133 Shares of AbbVie Inc. (NYSE:ABBV)B. Riley Wealth Advisors Inc. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 83,967 shares of the company's stock after selling 2,133 shares during thMay 27 at 7:18 AM | marketbeat.comHall Capital Management Co. Inc. Buys Shares of 15,985 AbbVie Inc. (NYSE:ABBV)Hall Capital Management Co. Inc. bought a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 15,985 shares of the company's stock, valued at approximately $2,841,000. AMay 27 at 6:47 AM | marketbeat.comCypress Asset Management Inc. TX Buys Shares of 3,748 AbbVie Inc. (NYSE:ABBV)Cypress Asset Management Inc. TX bought a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,748 shares of the company's stoMay 27 at 6:39 AM | marketbeat.comAmeriflex Group Inc. Takes $562,000 Position in AbbVie Inc. (NYSE:ABBV)Ameriflex Group Inc. acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 3,056 shares of the company's stock, valued at approximately $5May 27 at 6:31 AM | marketbeat.comSunbeam Capital Management LLC Takes $692,000 Position in AbbVie Inc. (NYSE:ABBV)Sunbeam Capital Management LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,892 shares of the company's stock, valued at approxiMay 27 at 6:30 AM | marketbeat.comAmerican Trust Boosts Stake in AbbVie Inc. (NYSE:ABBV)American Trust increased its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 185.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,111 shares of the company's stock after acquiring an additionalMay 27 at 6:21 AM | marketbeat.comAscent Group LLC Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)Ascent Group LLC increased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,936 shares of the company's stock after buying an additiMay 27 at 6:12 AM | marketbeat.com4,412 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Putney Financial Group LLCPutney Financial Group LLC acquired a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 4,412 shares of the company's stock, valued at approxiMay 27 at 6:03 AM | marketbeat.comPVG Asset Management Corp Makes New $425,000 Investment in AbbVie Inc. (NYSE:ABBV)PVG Asset Management Corp purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,391 shares of the company's stock, valued at apMay 27 at 5:55 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Mackenzie Financial CorpMackenzie Financial Corp grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 58.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,682,224 shares of the company's stock after purchasing an additionalMay 26, 2025 | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.210.87▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼7255▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today CORT News Today JAZZ News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABBV Stock Free ABBV Stock Alerts